News Kinnate Biopharma Sells Pan-RAF Inhibitor to Pierre Fabre Medicament by Warren Seah March 1, 2024 by Warren Seah March 1, 2024 Kinnate Biopharma, a clinical-stage precision oncology company, has recently finalized a deal with Pierre Fabre Medicament,… Read more